190 related articles for article (PubMed ID: 6302462)
21. Medullary differentiation of anaplastic thyroid carcinoma.
Nieuwenhuijzen Kruseman AC; Bosman FT; van Bergen Henegouw JC; Cramer-Knijnenburg G; Brutel de la Riviere G
Am J Clin Pathol; 1982 May; 77(5):541-7. PubMed ID: 6177234
[TBL] [Abstract][Full Text] [Related]
22. [Current perspectives of basic biology in medullary cancer of the thyroid].
Jullienne A; Moukhtar MS
Bull Cancer; 1984; 71(2):130-2. PubMed ID: 6610450
[No Abstract] [Full Text] [Related]
23. Different mechanisms of calcitonin, calcitonin gene-related peptide, and somatostatin regulation by glucocorticoids in a cell culture of human medullary thyroid carcinoma.
Cote GJ; Gagel RF
Henry Ford Hosp Med J; 1987; 35(2-3):149-52. PubMed ID: 2891648
[No Abstract] [Full Text] [Related]
24. Discordance between plasma calcitonin and tumor-cell mass in medullary thyroid carcinoma.
Trump DL; Mendelsohn G; Baylin SB
N Engl J Med; 1979 Aug; 301(5):253-5. PubMed ID: 449992
[No Abstract] [Full Text] [Related]
25. Immunohistochemical study of substance P-like immunoreactivity in human thyroid and medullary carcinoma of the thyroid.
Kakudo K; Vacca LL
J Submicrosc Cytol; 1983 Apr; 15(2):563-8. PubMed ID: 6687904
[TBL] [Abstract][Full Text] [Related]
26. Immunochemical heterogeneity of calcitonin in tumor, tumor venous effluent, and peripheral blood of patients with medullary thyroid carcinoma.
Heath H; Sizemore GW
J Lab Clin Med; 1979 Mar; 93(3):390-401. PubMed ID: 429850
[No Abstract] [Full Text] [Related]
27. Multiple endocrine cell types in thyroid medullary carcinoma. Evidence for calcitonin, somatostatin, ACTH, 5HT and small granule cells.
Capella C; Bordi C; Monga G; Buffa R; Fontana P; Bonfanti S; Bussolati G; Solcia E
Virchows Arch A Pathol Anat Histol; 1978 Feb; 377(2):111-28. PubMed ID: 205037
[TBL] [Abstract][Full Text] [Related]
28. Calcitonin heterogeneity in lung cancer and medullary thyroid cancer.
Becker KL; Snider RH; Silva OL; Moore CF
Acta Endocrinol (Copenh); 1978 Sep; 89(1):89-99. PubMed ID: 211777
[TBL] [Abstract][Full Text] [Related]
29. Application of non-commercial methods for estimation of immunoreactive serum calcitonin in clinical practice (comparison of two methods).
Bednár J; Neradilová M; Soutorová M; Bílek R; Nĕmec J; Pechová M; Havelka J
Czech Med; 1991; 14(4):205-12. PubMed ID: 1842705
[TBL] [Abstract][Full Text] [Related]
30. Adrenocorticotropin and calcitonin in medullary thyroid carcinoma: frequency of occurrence and localization in the same cell type by immunocytochemistry.
Goltzman D; Huang SN; Browne C; Solomon S
J Clin Endocrinol Metab; 1979 Sep; 49(3):364-9. PubMed ID: 224074
[No Abstract] [Full Text] [Related]
31. [Heterogeneity in the tissue calcitonin of medullary cancer with amyloid stroma].
Jullienne A; Raulais D; Cressent M; Moukhtar MS; Milhad G
C R Acad Hebd Seances Acad Sci D; 1977 Mar; 284(10):831-4. PubMed ID: 405113
[No Abstract] [Full Text] [Related]
32. Tumour calcitonin. Interaction with specific calcitonin receptors.
Ham J; Ellison ML; Lumsden J
Biochem J; 1980 Sep; 190(3):545-50. PubMed ID: 6258572
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical study of calcitonin gene-related peptide in human medullary carcinoma and C cell hyperplasia.
Williams ED; Ponder BJ; Craig RK
Clin Endocrinol (Oxf); 1987 Jul; 27(1):107-14. PubMed ID: 3498562
[TBL] [Abstract][Full Text] [Related]
34. Calcitonin in breast and lung cancer.
Hillyard CJ; Coombes RC; Greenberg PB; Galante LS; MacIntyre I
Clin Endocrinol (Oxf); 1976 Jan; 5(1):1-8. PubMed ID: 942890
[TBL] [Abstract][Full Text] [Related]
35. Molecular characterization of calcitonin gene-related peptide (CGRP) in a rat medullary thyroid carcinoma cell line.
Schifter S; Johansen TE; Johnsen AH
Peptides; 1995; 16(8):1489-96. PubMed ID: 8745063
[TBL] [Abstract][Full Text] [Related]
36. [Heterogeneity of human calcitonin].
Moukhtar MS; Jullienne-Moukhtar A; Raulais D; Taboulet J; Calmettes C; Milhaud G
C R Acad Hebd Seances Acad Sci D; 1975 Mar; 280(9):1127-30. PubMed ID: 811385
[TBL] [Abstract][Full Text] [Related]
37. Calcitonin, somatostatin and ACTH immunoreactive cells in a case of familial bilateral thyroid medullary carcinoma.
Charpin C; Andrac L; Monier-Faugere MC; Hassoun J; Cannoni M; Vagneur JP; Toga M
Cancer; 1982 Nov; 50(9):1806-14. PubMed ID: 6126268
[TBL] [Abstract][Full Text] [Related]
38. Plasma and tumor levels of somatostatin (SRIF) and somatostatin immunochemistry in medullary thyroid carcinoma: apparently discrepant preliminary results.
Franc B; Chayvialle JA; Modigliani E; Calmettes C; Caillou B; Dutrieux-Berger N; Houdent C; Kujas M
Henry Ford Hosp Med J; 1987; 35(2-3):147-8. PubMed ID: 2891647
[No Abstract] [Full Text] [Related]
39. Medullary carcinoma of the thyroid: histomorphological, histochemical and immunohistochemical analysis of twenty cases.
Kos M; Separović V; Sarcević B
Acta Med Croatica; 1995; 49(4-5):195-9. PubMed ID: 8630453
[TBL] [Abstract][Full Text] [Related]
40. Identification and characterization of calcitonin forms in plasma and urine of normal subjects and medullary carcinoma patients.
Tobler PH; Tschopp FA; Dambacher MA; Born W; Fischer JA
J Clin Endocrinol Metab; 1983 Oct; 57(4):749-54. PubMed ID: 6885964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
